In the BioHarmony Drug Report Database

"Preview" Icon

Brinzolamide

Azopt (brinzolamide) is a small molecule pharmaceutical. Brinzolamide was first approved as Azopt on 1998-04-01. It is used to treat open-angle glaucoma in the USA. It has been approved in Europe to treat ocular hypertension and open-angle glaucoma. The pharmaceutical is active against carbonic anhydrase 7. In addition, it is known to target carbonic anhydrase 12, carbonic anhydrase 14, carbonic anhydrase 1, and carbonic anhydrase 2.

 

Trade Name

 

Azopt
 

Common Name

 

brinzolamide
 

ChEMBL ID

 

CHEMBL220491
 

Indication

 

ocular hypertension, open-angle glaucoma
 

Drug Class

 

Carbonic anhydrase inhibitors

Image (chem structure or protein)

Brinzolamide structure rendering